AstraZeneca plc

AstraZeneca plc is one of the world’s largest biopharmaceutical companies, focused on the discovery, development, manufacturing, and commercialisation of prescription medicines. The company operates across major therapeutic areas including oncology, rare diseases, cardiovascular, renal and metabolic diseases, respiratory and immunology, and other specialist areas of medicine.

AstraZeneca’s strength comes from its research base, global pharmaceutical scale, and strong position in high-value treatment areas such as cancer, rare disease, and chronic disease management. Its oncology portfolio has become a major growth driver, while its broader biopharmaceutical business gives it exposure to long-term healthcare demand, ageing populations, innovation in targeted therapies, and rising need for treatments that address complex diseases. This makes AstraZeneca a major global healthcare platform with both defensive qualities and long-term growth potential from its medicines pipeline.